The "AAV Vectors in Gene Therapy - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.The Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline signifies a ...

The 7 major adeno-associated virus gene therapy market reached a value of USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 107.2 Billion by 2035, exhibiting a growth ...

that explores the potential of nanoneedle technology as a tool for advancing the understanding of adeno-associated virus (AAV) manufacturing processes and product quality. During AAV production ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

We previously dissected the components of the innate immune response to Helper-dependent adenoviral vectors (HDAds ... These results show that the type I IFN signaling dependent transgene silencing ...

Surviving extreme conditions in nature is no easy feat. Many species of mammals rely on special adaptations called daily ...

Genethon, a pioneering gene therapy research organization created by the AFM-Telethon, marks Rare Disease Day February 28, ...

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare ...

Advancements in technolgies like bioluminescent technology, proteomics and genomics tools can help in gene therapy using Adeno-associated virus (AAV), which has become one of the most promising ...

Shu is first expert from Asia to receive the award. According to ARO, Shu was awarded for his collaborative and continued ...